Experimental models of acute kidney injury for translational research

NA Hukriede, DE Soranno, V Sander… - Nature Reviews …, 2022 - nature.com
Preclinical models of human disease provide powerful tools for therapeutic discovery but
have limitations. This problem is especially apparent in the field of acute kidney injury (AKI) …

[HTML][HTML] Exploring the multifaceted potential of sildenafil in medicine

C Pușcașu, A Zanfirescu, S Negreș, OC Șeremet - Medicina, 2023 - mdpi.com
Phosphodiesterase type 5 (PDE5) is pivotal in cellular signalling, regulating cyclic
guanosine monophosphate (cGMP) levels crucial for smooth muscle relaxation and …

Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: thinking about new indications

M Ala, R Mohammad Jafari… - Fundamental & clinical …, 2021 - Wiley Online Library
Sildenafil, approved two decades ago, is the inhibitor of phosphodiesterase 5 (PDE5). First
of all, it was designated for angina pectoris, but soon it showed a wonderful efficacy in …

Nrf-2 as a therapeutic target in acute kidney injury

SM Hejazian, SMH Khatibi, A Barzegari… - Life sciences, 2021 - Elsevier
Multifaceted cellular pathways exhibit a crucial role in the preservation of homeostasis at the
molecular, cellular, and organism levels. One of the most important of these protective …

Large animal models for translational research in acute kidney injury

B Packialakshmi, IJ Stewart, DM Burmeister… - Renal failure, 2020 - Taylor & Francis
While extensive research using animal models has improved the understanding of acute
kidney injury (AKI), this knowledge has not been translated into effective treatments. Many …

[HTML][HTML] Current concepts on the reno-protective effects of phosphodiesterase 5 inhibitors in acute kidney injury: systematic search and review

G Georgiadis, IE Zisis, AO Docea, K Tsarouhas… - Journal of clinical …, 2020 - mdpi.com
Acute kidney injury (AKI) is associated with increased morbidity, prolonged hospitalization,
and mortality, especially in high risk patients. Phosphodiesterase 5 inhibitors (PDE5Is) …

Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury

K Thapa, TG Singh, A Kaur - Life sciences, 2021 - Elsevier
Abstract Aims Ischemia/reperfusion (I/R) occurs in renal artery stenosis, partial nephrectomy
and most commonly during kidney transplantation. It brings serious consequences such as …

Reno-protective effects of Phosphodiesterase 5 inhibitors

ER Coskuner, B Ozkan - Clinical and experimental nephrology, 2021 - Springer
The kidneys are vital organs that play an important role in removing waste materials from the
blood, electrolyte balance, blood pressure regulation, and red blood cell genesis. Kidney …

Inflammation in cerebral ischemia reperfusion improved by avanafil via nod-like receptor protein-3 inflammasome: an experimental study in rats

H Bekmez, MN Kocak, T Tavaci, H Halici, E Toktay… - Brain Injury, 2024 - Taylor & Francis
Objective The aim of study was to investigate the effect of avanafil, a second-generation
phosphodiesterase-5 (PDE5) inhibitor, on cerebral ischemia reperfusion (CI/R) model …

[PDF][PDF] Renoprotective effect of carbamylated darbepoetin and udenafil in ischemia-reperfusion of rat kidney due to the effect of preconditioning and inhibition of …

DA Kostina, TG Pokrovskaya, VY Poltev - 2021 - dspace.bsuedu.ru
Renoprotective effect of carbamylated darbepoetin and udenafil in ischemia-reperfusion of rat
kidney due to the effect of precon Page 1 Renoprotective effect of carbamylated darbepoetin …